Viskase Holdings, Inc.

ENZN

Enzon Pharmaceuticals, Inc. (together with its subsidiaries, the Company, Enzon, we or us ) is positioned as a public company acquisition vehicle. Historically, we have received royalty revenues from licensing arrangements with other companies primarily related to sales of certain drug products that utilized Enzon's proprietary technology.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$59M

EPS-$135.36

P/E-0.03

P/FCF-1.40

EV/EBITDA42.29

FCF Yield–

Div. Yield2.14%

Net Debt/FCF-9.8x

Viskase Holdings, Inc. intrinsic value

52-Week Range

$4.03$7.80

Profitability & Returns

TTM as of 2026-09 · YoY vs prior year · ROIC = NOPAT / invested capital

Revenue

N/A

Net Income (TTM)

-$7M

▼ -538.2% YoY

Op. Margin

–

ROIC

2.57%

▼ -246.8pp YoY

Cash Flow & Balance Sheet

FCF = operating cash flow + capex · Net debt = total debt − cash · Balance sheet from latest filing

FCF (TTM)

-$43M

▼ -368.3% YoY

Op. Cash Flow (TTM)

-$43M

▼ -368.3% YoY

Net Debt

$419M

Cash & Equiv.

$8M

5Y CAGR: -67.3%

Continue Research

Quality Scorecard

Is this a high-quality business?

Dividends

Payout safety and growth

Intrinsic Value

What is it worth?

Financials

Full income, cash flow, balance sheet

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ENZN

CompareIntrinsic value

SNTISenti Biosciences Inc.

$0.18-0.79%0

CELZCreative Medical Technology Holdings Inc.

$0.65-3.21%10

INMBInmune Bio Inc.

$1.33+0.76%10

AIMAIM ImmunoTech Inc.

$0.16+0.63%15

VIVSVivoSim Labs, Inc.

$0.15+8.71%10

ATYRAtyr Pharma Inc.

$6.18-6.79%10

WINTWindtree Therapeutics Inc.

$0.00+0.00%10

ZIVOZivo Bioscience Inc.

$8.00+10.34%0

Viskase Holdings (ENZN) in three numbers

Quality score: 0/100; Best check: revenue growth, -20.6%.; Quality
Dividend (TTM): $34.98; 2.14% yield, not raised in the latest year.; Dividends
P/E: -0.03; Negative: a loss over the last twelve months. Price to free cash flow -1.40.; Financials

Questions about Viskase Holdings

Is Viskase Holdings a high-quality business?

Viskase Holdings scores 0 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from SEC filings. Its best check is revenue growth at -20.6%. The Quality tab shows every check against its target.

Does Viskase Holdings (ENZN) pay a dividend, and how much?

Yes. Viskase Holdings (ENZN) pays a dividend: $34.98 per share over the last twelve months, a dividend yield of 2.14% at the latest close. Its dividend per share has grown at 0.0% a year over the last 2 years. The Dividends tab has the full payment history and the safety score.

Source: 10-Q filed 1 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in ENZN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ENZN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.